How a creatine-like drug affects cancer cells
Cyclocreatine transport and cytotoxicity in rat glioma and human ovarian carcinoma cells: 31P-NMR spectroscopy.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Surprising Findings
Cyclocreatine stops cancer cell growth without depleting energy stores or damaging membranes.
Most cancer drugs either damage DNA, disrupt energy production, or break cell membranes. This drug works without any of those common mechanisms.
Practical Takeaways
Cyclocreatine may be more effective in tumors with high glucose availability due to its glucose-sensitive transport in C6 cells.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Surprising Findings
Cyclocreatine stops cancer cell growth without depleting energy stores or damaging membranes.
Most cancer drugs either damage DNA, disrupt energy production, or break cell membranes. This drug works without any of those common mechanisms.
Practical Takeaways
Cyclocreatine may be more effective in tumors with high glucose availability due to its glucose-sensitive transport in C6 cells.
Publication
Journal
The American journal of physiology
Year
1996
Authors
Y. Schiffenbauer, G. Meir, M. Cohn, M. Neeman
Related Content
Claims (4)
Cyclocreatine slows down the growth of certain cancer cells in a lab dish, but it doesn’t harm their outer layer or energy supply — so it probably works in a different way.
When scientists gave a substance called cyclocreatine to two types of cancer cells, one kind (from rat brain tumors) stored a modified version of it, but the other kind (from human ovarian tumors) didn't — meaning these cells handle the substance differently.
In rat brain tumor cells, a substance called cyclocreatine gets pulled in using energy and sodium, but when sugar levels drop, this process slows down a lot—showing it needs energy from sugar to work well.
Cyclocreatine kills brain tumor cells in rats by making them swell up, but it stops ovarian cancer cells in humans in a totally different way we don’t yet understand.